发明名称 FC VARIANTS
摘要 The present disclosure relates to polypeptide variants having modified Fc domains with altered affinity to Fc receptors.
申请公布号 US2014377253(A1) 申请公布日期 2014.12.25
申请号 US201414214146 申请日期 2014.03.14
申请人 ABBVIE BIOTHERAPEUTICS INC. 发明人 HARDING Fiona A.;HINTON Paul R.;XIONG Mengli;RAZO Olivia Jennifer;YE Shiming
分类号 C07K16/28;C07K16/24 主分类号 C07K16/28
代理机构 代理人
主权项 1. A polypeptide comprising a variant CH2 domain which has at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98% or at least 99% sequence identity to the CH2 domain of SEQ ID NO:2, and which has relative to the CH2 domain of SEQ ID NO:2 one or more substitutions selected from: (a) a V263 substitution that increases affinity towards FcγRIIB and decreases affinity towards FcγRIIIA; (b) a V266 substitution that increases affinity towards FcγRIIB and decreases affinity towards FcγRIIIA; and (c) a V273 substitution that increases affinity towards FcγRIIB and decreases affinity towards FcγRIIIA.
地址 Redwood City CA US